Ascendis Pharma A (ASND) Assets Average (2013 - 2026)

Ascendis Pharma A has disclosed Assets Average across 13 years of filings, most recently posting $1.9 billion for Q1 2026.

• Assets Average for Q1 2026 came in at $1.9 billion, down 13.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.9 billion (down 13.75% YoY), and the FY2025 annual result was $2.4 billion, up 14.78% from the prior year.
• Assets Average came in at $1.9 billion for Q1 2026 at Ascendis Pharma A, up from $1.4 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $2.3 billion in Q4 2024 to a low of $844.2 million in Q2 2024.
• The 5-year median for Assets Average is $1.2 billion (2022), against an average of $1.3 billion.
• Across the five-year window, Assets Average plunged 43.91% in 2023 and surged 154.39% in 2025, its largest moves.
• Ascendis Pharma A's Assets Average stood at $1.2 billion in 2022, then decreased by 23.25% to $919.4 million in 2023, then jumped by 148.1% to $2.3 billion in 2024, then plunged by 37.17% to $1.4 billion in 2025, then soared by 34.73% to $1.9 billion in 2026.
• The last three Assets Average figures came in at $1.9 billion (Q1 2026), $1.4 billion (Q4 2025), and $1.3 billion (Q3 2025), per Business Quant data.